The BoSS program, hosted by ARPA-H) is focused on developing technologies to produce, store, and ship biologic medicines and cell therapies at room temperature, eliminating the need for ultra-cold storage. The program is open to organizations, researchers, and industry partners capable of developing and scaling innovative biostabilization and cell processing systems.

Solution Summaries due February 19, 2026, and proposals from IV & V potential partners due April 17, 2026. Interested parties can learn more on the site.